Keyphrases
Myxomatous Mitral Valve Disease
83%
Serotonin
60%
Cavalier King Charles Spaniel
53%
Mitral Regurgitation
38%
Left Ventricular Function
35%
5-hydroxytryptamine
34%
Mitral Valve
27%
Serotonin 2A Receptor (5-HT2AR)
25%
Serum Serotonin
21%
Platelet-rich Plasma
21%
Left Ventricular Hypertrophy
19%
Porcine Model
19%
Acylated Ghrelin
19%
Analytical Validation
19%
Experimental pigs
19%
Mitral Valve Leaflets
19%
α-smooth muscle Actin (α-SMA)
19%
Left Ventricular Enlargement
19%
Concentration Bounds
19%
Platelet-derived Microparticles
19%
Eccentric Hypertrophy
19%
5-hydroxyindoleacetic Acid (5-HIAA)
19%
CD61
19%
Platelet Secretome
19%
Surface Binding
19%
Myocardial Tissue
19%
Annexin V
19%
Transcription Level
19%
Ischemic Mitral Regurgitation
19%
Papillary muscle
17%
Microparticle Concentration
16%
Serotonin Reuptake Transporter
16%
Valvular
15%
Veterinary Science and Veterinary Medicine
Platelet
100%
Dog
80%
Myxomatous Mitral Valve Disease
63%
Blood Plasma
47%
Canine
46%
Mitral Insufficiency
38%
Mitral Valve Regurgitation
38%
Cavalier King Charles Spaniel
35%
Muscle
27%
Thrombin
19%
Ghrelin
19%
Pig
19%
Cat
19%
Left Ventricular Hypertrophy
19%
Heart Left Ventricle Hypertrophy
19%
Biochemistry, Genetics and Molecular Biology
Platelet
44%
Secretome
38%
Proteomics
38%
Thrombin
38%
Serotonin
25%
Myofibroblast
21%
Porcine Model
19%
5-HT2A Receptor
19%
Actin
19%
Transcription
19%
